Literature DB >> 12113489

Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies.

M H Kyaw1, B Wayne, J Chalmers, I G Jones, H Campbell.   

Abstract

A survey of the coverage, distribution and the factors associated with use of influenza and pneumococcal vaccines among general practitioners (GPs) in primary care and in hospital settings was carried out in 53 general practices in Scotland taking part in the 'Continuous Morbidity Recording' (CMR) programme. The annual vaccine distribution increased substantially among 53 general practices from 1993 to 1999 and in Scotland as a whole from 1984 to 1999. From the questionnaire, overall coverage was 43% (95% CI 38-48) for influenza vaccine in the 2000-1 season and 13% (95% CI 9-16) for pneumococcal vaccine in the last 5 year period, in high-risk patients recommended for these vaccines by the Department of Health (DoH). Influenza vaccine coverage was highest in the elderly (65 years of age and above) at 62% (95% CI 59-74). Although pneumococcal vaccination is not currently recommended for all elderly, coverage of this vaccine was also higher in this group (22%, 95% CI 16-29). In the majority of patients (influenza vaccine, 98% and pneumococcal vaccine, 94%), vaccination was carried out in general practice. Only 2% of patients had received pneumococcal vaccination in a hospital setting. The level of influenza and pneumococcal vaccination varied with the level of deprivation. Most GPs considered that the responsibility for influenza and pneumococcal vaccination lay with them. Forty-five percent of GPs reported having a written policy with set target for influenza vaccination and 11% for pneumococcal vaccination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113489      PMCID: PMC2869841          DOI: 10.1017/s0950268802006891

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

2.  Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework.

Authors:  G McLean; M Sutton; B Guthrie
Journal:  J Epidemiol Community Health       Date:  2006-11       Impact factor: 3.710

Review 3.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

4.  The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales.

Authors:  Alessia Melegaro; W John Edmunds
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland.

Authors:  N F Murphy; C R Simpson; F A McAlister; S Stewart; K MacIntyre; M Kirkpatrick; J Chalmers; A Redpath; S Capewell; J J V McMurray
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

6.  A qualitative study of lay beliefs about influenza immunisation in older people.

Authors:  Meirion R Evans; Hayley Prout; Lindsay Prior; Lorna M Tapper-Jones; Chris C Butler
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

Review 7.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

8.  Influenza vaccination in pregnancy: vaccine uptake, maternal and healthcare providers' knowledge and attitudes. A quantitative study.

Authors:  Tina Barrett; Edel McEntee; Richard Drew; Fiona O'Reilly; Austin O'Carroll; Aisling O'Shea; Brian Cleary
Journal:  BJGP Open       Date:  2018-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.